Cedar Brook Financial Partners, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cedar Brook Financial Partners, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50,773
-12.9%
130,5220.0%0.01%
-7.1%
Q2 2023$58,278
-32.2%
130,522
+24.4%
0.01%
-36.4%
Q1 2023$86,002
-37.9%
104,881
+18.2%
0.02%
-43.6%
Q4 2022$138,450
-9.6%
88,7500.0%0.04%
-20.4%
Q3 2022$153,094
-0.6%
88,7500.0%0.05%
+2.1%
Q2 2022$154,000
-51.7%
88,7500.0%0.05%
-42.2%
Q1 2022$319,000
+17.3%
88,750
+62.8%
0.08%
+18.6%
Q4 2021$272,000
-30.3%
54,5000.0%0.07%
-40.2%
Q3 2021$390,000
-22.8%
54,5000.0%0.12%
-19.9%
Q2 2021$505,000
-0.2%
54,5000.0%0.15%
-16.6%
Q1 2021$506,000
+5.0%
54,5000.0%0.18%
+2.3%
Q4 2020$482,000
-24.3%
54,500
-0.7%
0.17%
-31.6%
Q3 2020$637,000
-57.0%
54,9000.0%0.25%
-62.1%
Q2 2020$1,480,000
+265.4%
54,900
+0.7%
0.66%
+192.9%
Q1 2020$405,000
+195.6%
54,500
+31.3%
0.22%
+287.9%
Q4 2019$137,000
+61.2%
41,5000.0%0.06%
+56.8%
Q3 2019$85,000
-30.3%
41,5000.0%0.04%
-33.9%
Q2 2019$122,000
-21.3%
41,5000.0%0.06%
-25.3%
Q1 2019$155,000
-6.6%
41,5000.0%0.08%
-25.7%
Q4 2018$166,00041,5000.10%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders